Literature DB >> 9305296

Clostridium difficile infection in obstetric and gynecologic patients.

A H James1, V L Katz, D J Dotters, R G Rogers.   

Abstract

We reviewed hospital records of women on the obstetrics and gynecologic services with a diagnosis of antibiotic-associated diarrhea, pseudomembranous colitis, or Clostridium difficile infection to better characterize the incidence and course of women with C difficile infection. Cases were included if there was identification of C difficile by culture or toxin or endoscopic verification of pseudomembranous colitis. Between January 1985 and June 1995, there were 74,120 admissions to the obstetrics and gynecology services at two tertiary level hospitals. Eighteen women were found to have documented C difficile infection (0.02%)--3 from the obstetric services, 10 from the benign gynecologic services, and 5 from the gynecologic/oncology services. Diarrhea developed from 2 days to 30 days after antibiotics had been given (mean, 10 days). Nine patients had fever, six had nausea and vomiting, and five had abdominal pain. Antimicrobial agents given before infection included cephalexin, cefoxitin, imipenem, ciprofloxacin, trimethoprim/sulfamethoxazole, ampicillin, gentamicin, and clindamycin. All patients were treated successfully with inpatient antimicrobial agents-15 with metronidazole and 3 with vancomycin. There was one possible recurrence.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9305296     DOI: 10.1097/00007611-199709000-00004

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  6 in total

1.  Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA).

Authors:  L Clifford McDonald; Dale N Gerding; Stuart Johnson; Johan S Bakken; Karen C Carroll; Susan E Coffin; Erik R Dubberke; Kevin W Garey; Carolyn V Gould; Ciaran Kelly; Vivian Loo; Julia Shaklee Sammons; Thomas J Sandora; Mark H Wilcox
Journal:  Clin Infect Dis       Date:  2018-03-19       Impact factor: 9.079

2.  Clostridium difficile infection in fever patients with gynecological malignancies.

Authors:  Shintaro Yanazume; Akio Tokudome; Mika Fukuda; Shinichi Togami; Masaki Kamio; Shunichiro Ota; Hiroaki Kobayashi
Journal:  Cancer Rep (Hoboken)       Date:  2019-07-22

Review 3.  Variable spectrum of disease and risk factors of peripartum Clostridium difficile infection: report of 14 cases from French hospitals and literature review.

Authors:  Claire de Curraize; Clotilde Rousseau; Stéphane Corvec; Najoua El-Helali; Vincent Fihman; Frédéric Barbut; Anne Collignon; Alban Le Monnier
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-09-03       Impact factor: 3.267

Review 4.  Comparison of pediatric and adult antibiotic-associated diarrhea and Clostridium difficile infections.

Authors:  Lynne Vernice McFarland; Metehan Ozen; Ener Cagri Dinleyici; Shan Goh
Journal:  World J Gastroenterol       Date:  2016-03-21       Impact factor: 5.742

5.  The emergence of Clostridium difficile infection among peripartum women: a case-control study of a C. difficile outbreak on an obstetrical service.

Authors:  Jennifer A Unger; Estella Whimbey; Michael G Gravett; David A Eschenbach
Journal:  Infect Dis Obstet Gynecol       Date:  2011-07-24

Review 6.  Clostridium difficile Infection in Special High-Risk Populations.

Authors:  Alberto Cózar-Llistó; Antonio Ramos-Martinez; Javier Cobo
Journal:  Infect Dis Ther       Date:  2016-08-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.